Search results for "Highlights"

Results 61 - 70 of about 379 for "Highlights".
Sort by: Relevance | Newest | Oldest

Consensus report issued on management of type 1 diabetes in adults

The report from the American Diabetes Association and European Association for the Study of Diabetes offers guidance on diagnosis, management, and treatment, among other topics. Their recommendations are evidence-based where possible but represent the consensus opinion of the authors.
8 Oct 2021

Studies find link between metformin and reduced COVID-19 mortality, mixed results for DPP-4 inhibitors

Prior metformin use was associated with a threefold decrease in mortality from COVID-19 in one study of patients with type 2 diabetes, while three other studies found mixed results on whether dipeptidyl peptidase-4 (DPP-4) inhibitors affect COVID-19 outcomes.
12 Feb 2021

Biomarker score predicts heart failure risk with diabetes and prediabetes

The score, which was based on cardiac troponin, N-terminal pro-B-type natriuretic peptide, C-reactive protein, and electrocardiography, could be used to target specific therapies to the highest-risk patients, study authors said.
8 Jan 2021

Surgical, drug treatments have similar outcomes in patients with vitreous hemorrhage from proliferative diabetic retinopathy

A randomized trial found equivalent improvements in visual acuity at two years with either therapy but identified some differences in outcomes that could help patients and clinicians choose a treatment method.
8 Jan 2021

Patients with type 2 diabetes and all risk factors controlled still have increased CVD risk

Risk factor control was more strongly associated with mortality risk among patients with cardiorenal disease than those without, according to a retrospective British study.
11 Dec 2020

Balanced crystalloids may be preferred for acute resolution of diabetic ketoacidosis

A small subgroup analysis of two randomized trials found that median time to resolution of diabetic ketoacidosis was 13 hours in patients who received balanced crystalloids versus nearly 17 hours in those who received saline.
11 Dec 2020

One-time serum C-peptide testing detected patients misclassified as having type 1 diabetes

In a recent study, a serum C-peptide testing program resulted in reclassification of the cause of diabetes in about 7% of the cohort tested at one diabetes center in Scotland. Reclassification was most likely in those diagnosed at age 30 years or older.
13 Nov 2020

In type 2 diabetes patients, lower LDL cholesterol levels after PCI associated with better outcomes

A pooled analysis of three randomized clinical trials found reductions in major adverse cardiac or cerebrovascular events after percutaneous coronary intervention (PCI) at 3.9-year follow-up only in patients with low-density lipoprotein (LDL) cholesterol levels below 70 mg/dL at one year.
13 Nov 2020

AHA scientific statement reviews research on drugs for diabetes and chronic kidney disease

The advent of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists could reduce cardiovascular adverse events and progression to end-stage kidney disease, the American Heart Association (AHA) scientific statement noted.
9 Oct 2020

Patients with type 2 diabetes at higher risk for AKI, even without pre-existing kidney disease

The authors of the retrospective study called for additional research on the pathogenesis of acute kidney injury (AKI) and the associated risk factors, such as medications, in diabetic patients.
9 Oct 2020

Result Page: Prev   2   3   4   5   6   7   8   9   10   11   Next